Anampa JD, Flynn DL, Leary C, Oh S, et al. Phase Ib clinical and pharmacodynamic study of the TIE2 kinase inhibitor rebastinib with paclitaxel or eribulin in HER2-negative metastatic breast cancer. Clin Cancer Res 2024 Nov 12. doi: 10.1158/1078-0432.CCR-24-2464.
PMID: 39531537